Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
8.65
+0.18 (2.13%)
May 2, 2025, 4:00 PM EDT - Market closed
Viatris Revenue
In the year 2024, Viatris had annual revenue of $14.74B, down -4.46%. Viatris had revenue of $3.53B in the quarter ending December 31, 2024, a decrease of -8.06%.
Revenue (ttm)
$14.74B
Revenue Growth
-4.46%
P/S Ratio
0.70
Revenue / Employee
$460,603
Employees
32,000
Market Cap
10.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14.74B | -687.60M | -4.46% |
| Dec 31, 2023 | 15.43B | -835.80M | -5.14% |
| Dec 31, 2022 | 16.26B | -1.62B | -9.08% |
| Dec 31, 2021 | 17.89B | 5.94B | 49.73% |
| Dec 31, 2020 | 11.95B | 445.50M | 3.87% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Thermo Fisher Scientific | 42.90B |
VTRS News
- 17 hours ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - Accesswire
- 18 hours ago - VTRS FRAUD NOTICE: Viatris Inc. (NASDAQ:VTRS) Investors may have been affected by Fraud -- Contact BFA Law by June 3 Court Deadline - GlobeNewsWire
- 3 days ago - VTRS ANNOUNCEMENT: Viatris Inc. Investors May Have Been Affected by Fraud - Contact BFA Law Before June 3 Court Deadline - Accesswire
- 4 days ago - VTRS NEWS: Viatris Inc. has Been Sued for Securities Fraud - Investors are Alerted to Contact BFA Law - Accesswire
- 6 days ago - VTRS SHAREHOLDER REVIEW: Viatris Inc. (NASDAQ:VTRS) was Sued for Fraud after 15% Stock Drop – Investors are Urged to Contact BFA Law - GlobeNewsWire
- 8 days ago - Viatris to Present at the BofA Securities 2025 Healthcare Conference - PRNewsWire
- 12 days ago - VTRS LEGAL REMINDER: Did Viatris Inc. Commit Securities Fraud? Contact BFA Law before June 3 Court Deadline (NASDAQ:VTRS) - GlobeNewsWire
- 12 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga